1. Home
  2. LSTA vs NDLS Comparison

LSTA vs NDLS Comparison

Compare LSTA & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NDLS
  • Stock Information
  • Founded
  • LSTA 1980
  • NDLS 1995
  • Country
  • LSTA United States
  • NDLS United States
  • Employees
  • LSTA N/A
  • NDLS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NDLS Restaurants
  • Sector
  • LSTA Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • LSTA 22.5M
  • NDLS 32.9M
  • IPO Year
  • LSTA N/A
  • NDLS 2013
  • Fundamental
  • Price
  • LSTA $2.72
  • NDLS $0.90
  • Analyst Decision
  • LSTA Strong Buy
  • NDLS Strong Buy
  • Analyst Count
  • LSTA 1
  • NDLS 2
  • Target Price
  • LSTA $15.00
  • NDLS $3.00
  • AVG Volume (30 Days)
  • LSTA 23.5K
  • NDLS 224.0K
  • Earning Date
  • LSTA 08-11-2025
  • NDLS 08-06-2025
  • Dividend Yield
  • LSTA N/A
  • NDLS N/A
  • EPS Growth
  • LSTA N/A
  • NDLS N/A
  • EPS
  • LSTA N/A
  • NDLS N/A
  • Revenue
  • LSTA $1,000,000.00
  • NDLS $495,670,000.00
  • Revenue This Year
  • LSTA N/A
  • NDLS $5.37
  • Revenue Next Year
  • LSTA N/A
  • NDLS $0.68
  • P/E Ratio
  • LSTA N/A
  • NDLS N/A
  • Revenue Growth
  • LSTA N/A
  • NDLS N/A
  • 52 Week Low
  • LSTA $1.87
  • NDLS $0.55
  • 52 Week High
  • LSTA $4.20
  • NDLS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 52.43
  • NDLS 61.53
  • Support Level
  • LSTA $2.34
  • NDLS $0.66
  • Resistance Level
  • LSTA $3.09
  • NDLS $0.82
  • Average True Range (ATR)
  • LSTA 0.25
  • NDLS 0.08
  • MACD
  • LSTA 0.01
  • NDLS 0.02
  • Stochastic Oscillator
  • LSTA 50.67
  • NDLS 93.68

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: